The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic. - Wikidata - awgldk - TriplyDB

The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.

The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.

http://www.wikidata.org/entity/Q41673511

about

Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease Relationship between psoriasis and non-alcoholic fatty liver disease.Noninvasive Testing for Nonalcoholic Steatohepatitis and Hepatic Fibrosis in Patients With Psoriasis Receiving Long-term Methotrexate Sodium Therapy.Liver test abnormalities in patients admitted for severe psoriasis: prevalence and associated risk factors.Significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the US: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey.Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis.Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.

P2860

Q26765175-B3DEAEDE-4144-454B-8517-1F36378E2526 Q26767276-266A0B06-73FA-423B-8A01-B052589E10E9 Q36921610-B6E77C14-E603-43ED-BE01-321DC6382E7C Q37553636-D29E0B68-880E-49F5-B04A-ADA93AC1577D Q38612446-60CE8AC8-39A1-4393-A13F-D7E22E6D197A Q39735574-BC0C84D9-C837-4438-9BA7-95CC0B16CD7C Q40039094-EDB0F351-54FF-423D-B403-192E5D89DC26 Q41150051-35FA87FB-47C5-4838-81B8-C7F056F9E331 Q48105587-AF40BB43-557C-4EDC-9200-C6681D2B0382

P2860

The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.

http://www.wikidata.org/entity/Q41673511

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The prevalence of NAFLD and NA ...... ology and rheumatology clinic.

@en

type

label

The prevalence of NAFLD and NA ...... ology and rheumatology clinic.

@en

prefLabel

The prevalence of NAFLD and NA ...... ology and rheumatology clinic.

@en

P1433

Q41673511-73DE40EF-3BBD-47E1-9C70-2A686F14FE95

P1476

Q41673511-F39ECAD2-C1ED-497B-9998-57CADAA555E0

P2093

Q41673511-1B7F725E-5CD1-4BF6-9CA7-003579975C14

Q41673511-25EB944D-B419-4479-A78E-81E07D6087C5

Q41673511-5A1DACD8-1C8C-49A3-8826-709EDAB2210A

Q41673511-7AA847B8-AE24-4E4F-9B58-86DBCFDC46C7

Q41673511-864898C5-7A2B-4C5E-B522-FD0BEF41D8E9

Q41673511-94E39251-F112-4D0C-BC93-0C6E6DF4CC08

Q41673511-ABCD372B-5413-42D0-945D-49FEAF53C627

P2860

Q41673511-08D124D4-9105-4D57-936D-F7479341E900

Q41673511-0A19D71E-7A80-49A9-B7CE-5FDBDF8D924C

Q41673511-0C4248DB-C144-4FBC-A8A6-1FBF1E3EFE44

Q41673511-347942D0-3C56-42E4-8142-951C6AB2F179

Q41673511-5B681823-09A9-4106-ADED-EE2B41169DBC

Q41673511-5E6F2D6D-DE72-492F-B137-CAFA515FCD28

Q41673511-6C39AEE2-91B7-4541-B4FD-12051900C46C

Q41673511-772C4FEA-C72A-4B07-A557-33D334BE47E4

Q41673511-893B6E7D-950C-496C-995A-03D9CB70A1D1

Q41673511-99358FDB-859B-450A-ACB8-D2BB5EA2139C

P304

Q41673511-81E33EE9-B0EC-4890-A9F0-590C27EC8616

P31

Q41673511-5AF247A9-D6F9-4327-BB65-A3B2A37D7958

P356

Q41673511-6C1BD7F6-4B85-4448-8E65-892F06EFF73E

P407

Q41673511-84FDB224-8FC5-44B9-A1C6-4B118ED8EED6

P433

Q41673511-66BC7B00-6815-43CE-B891-691A11DF710B

P478

Q41673511-8D64631D-4C78-45F8-A684-F814A2BEFA75

P577

Q41673511-DBB10EC6-39C0-4C0A-8037-DD08E53D3FC5

P698

Q41673511-4365600D-DCC4-43B3-8DF3-3A55BE37631D

P356

P1433

Alimentary Pharmacology & Therapeutics

P1476

The prevalence of NAFLD and NA ...... ology and rheumatology clinic.

@en

P2093

A E Cochet

http://www.w3.org/2001/XMLSchema#string

D F Battafarano

http://www.w3.org/2001/XMLSchema#string

E M Brunt

http://www.w3.org/2001/XMLSchema#string

K K Roberts

http://www.w3.org/2001/XMLSchema#string

P B Lamb

http://www.w3.org/2001/XMLSchema#string

P J Brown

http://www.w3.org/2001/XMLSchema#string

S A Harrison

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Psoriasis, the liver, and the gastrointestinal tract.

Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study

Comorbidities in patients with psoriasis.

Psoriasis and non-alcoholic fatty liver disease.

Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.

Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.

Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.

P304

293-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APT.13042

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25521607

http://www.w3.org/2001/XMLSchema#string